BioPharma, Pharma Digital Medicines Sector Draws Lessons From Pear Therapeutics’ Demise By Frank Vinluan
Health Tech, MedCity Influencers What Pear Therapeutics’ Bankruptcy Has Left the DTX Industry to Ponder By Dave Hanaman
Devices & Diagnostics, BioPharma Pear Therapeutics Files for Bankruptcy and Plans for Asset Auction in May By Frank Vinluan
Devices & Diagnostics, Payers Pear Therapeutics’ Cuts Are Not Enough; ‘Strategic Alternatives’ Among Next Steps By Frank Vinluan
BioPharma, Devices & Diagnostics Pear Therapeutics pares down its plans as restructuring cuts 9% of workforce By Frank Vinluan
Health Tech, Pharma ‘Smart pill’ startup etectRx strikes partnership with Pear Therapeutics By Elise Reuter
Pharma Novartis teams up with Pear Therapeutics to develop digital therapeutics for schizophrenia, MS By Stephanie Baum
Health IT Pear Therapeutics gets greenlight from FDA for addiction treatment via digital therapeutic By Stephanie Baum
Health IT, Daily Pear Therapeutics raises $20M for digital therapeutics portfolio aimed at substance abuse, schizophrenia By Stephanie Baum
BioPharma, Health Tech Pear, Ironwood have gut instinct for digital therapeutics with new partnership By Alaric DeArment
BioPharma, Devices & Diagnostics Click Expands to Substance Use Disorder With Indivior Digital Therapeutics Pact By Frank Vinluan
